Amturnide - Aliskiren Hemifumarate and Amlodipine Besylate and Hydrochlorothiazide
Navigation: NDC > Supplier starting with: N > NOVARTIS PHARMACEUTICALS CORPORATION| Field | Value |
|---|---|
| NDC Code: | 0078-0613 |
| Proprietary Name: | Amturnide |
| Suffix: | |
| Non-Proprietary Name: | Aliskiren Hemifumarate and Amlodipine Besylate and Hydrochlorothiazide |
| Dosage Form: | TABLET, FILM COATED |
| Method: | ORAL |
| Original Marketing Date: | 21-12-2010 |
| Category Name: | NDA |
| Application Number: | NDA200045 |
| Labeler: | NOVARTIS PHARMACEUTICALS CORPORATION |
| Substance Name: | ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE |
| Active Numerator Strength: | 300; 10; 12.5 |
| Active Ingredient Unit: | mg/1; mg/1; mg/1 |
| Pharm Classes: | Renin Inhibitor [EPC],Renin Inhibitors [MoA],Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
| DEA Schedule: |